SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,024,445 | -65.5% | 37,158 | -62.4% | 0.01% | -69.2% |
| Q2 2023 | $2,972,572 | -33.6% | 98,888 | -20.0% | 0.03% | -39.5% |
| Q1 2023 | $4,479,223 | +90.5% | 123,633 | +87.6% | 0.04% | +115.0% |
| Q4 2022 | $2,350,831 | +313.2% | 65,905 | +292.3% | 0.02% | +300.0% |
| Q3 2022 | $569,000 | -77.9% | 16,800 | -78.9% | 0.01% | -78.3% |
| Q1 2022 | $2,579,000 | +618.4% | 79,801 | +548.8% | 0.02% | +666.7% |
| Q4 2021 | $359,000 | -55.1% | 12,300 | -38.4% | 0.00% | -95.9% |
| Q3 2017 | $799,000 | – | 19,967 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |